Skip to main content
Monday, November 16, 2026Nov 16

Chattanooga investors figure in plans for Atlanta medical firm

An Atlanta medical device developer is getting a dose of new capital from Chattanooga where the research and development company will soon put down new roots.

Atlanta Catheter Therapies Inc. has raised nearly $3 million in new equity, including $2.3 million from a consortium of Chattanooga investors. The cash and equity investment will help the company bring to market a new type of intravascular agent delivery device which could someday replace stents used to open blocked heart arteries.

“These a very small catheters that go into your blood system and our agent delivery device is very innovative and we think is really cutting edge technology,” ACT President Paul J. Fitzpatrick said.

Fitzpatrick, a 24-year veteran of medical business startups, said Friday the new funding for ACT “will accelerate progress” of the company’s first product known as the occlusion perfusion catheter, or OPC. The company also is pursing at least a half dozen other technologies in the pipeline.

In spite of the name of Atlanta Catheter Therapies, the company plans to soon relocate into the former Medium offices at 50 E. Main St. on Chattanooga’s Southside.